Advances in acute toxicity testing: strengths, weaknesses and regulatory acceptance - PubMed (original) (raw)

Advances in acute toxicity testing: strengths, weaknesses and regulatory acceptance

Earnest Oghenesuvwe Erhirhie et al. Interdiscip Toxicol. 2018 May.

Abstract

Safety assessment of chemicals, pharmaceuticals, food and food ingredients, cosmetics, industrial products is very crucial prior to their approval for human uses. Since the commencement of toxicity testing (about 500 years ago, since 1520), significant advances have been made with respect to the 3Rs (reduction, refinement and replacement) alternative approaches. This review is focused on the update in acute systemic toxicity testing of chemicals. Merits and demerits of these advances were also highlighted. Traditional LD50 test methods are being suspended while new methods are developed and endorsed by the regulatory body. Based on the refinement and reduction approaches, the regulatory body has approved fixed dose procedure (FDP), acute toxic class (ATC) method and up and down procedure (UDP) which involves few numbers of animals. In terms of replacement approach, the regulatory body approved 3T3 neutral red uptake (NRU), the normal human keratinocyte (NHK), and the 3T3 neutral red uptake (NRU) phototoxicity test for acute phototoxicity. However, other promising replacement alternatives such as organ on chip seeded with human cells for acute systemic toxicity and 3T3 neutral red uptake (NRU) cytotoxicity test for identifying substances not requiring classification, as well as the in silico approaches are yet to receive regulatory approval. With this backdrop, a collaborative effort is required from the academia, industries, regulatory agencies, government and scientific organizations to ensure speedily regulatory approval of the prospective alternatives highlighted.

Keywords: 3Rs principles; acute toxicity; in silico; in vitro; in vivo; regulatory approval; toxicity testing.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ambuja SB, Elaina K, Thomas JF, John CL, Donna LM, Thomas H, Geoffrey WP. Correlating in vitro data to in vivo findings for risk assessment. Altex. 2013;31:1/14. Symposium report. - PubMed
    1. Arwa BR, Vladimir BB. In silico toxicology: computational methods for the prediction of chemical toxicity. Wiley Interdiscip Rev Comput Mol Sci. 2016;6:147–172. - PMC - PubMed
    1. Blais A, Morvan-Baleynaud J, Friedlander G, Le Grimellec C. Primary culture of rabbit proximal tubules as a cellular model to study nephrotoxicity of xenobiotics. Kidney Int. 1993;44:13–18. - PubMed
    1. Botham PA. Acute systemic toxicity—prospects for tiered testing strategies. Toxicol in Vitro. 2004;18:227–230. - PubMed
    1. Broadhead CL, Combes RD. The current status for food additives toxicity testing and the potential for application of the Three Rs. ATLA. 2001;29:471–485. - PubMed

LinkOut - more resources